Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa

•the rapid rise and decline of admissions and decreased severity of COVID-19 disease•compares 466 patients in the Omicron wave to 3962 patients in previous waves•describes disease severity of all admitted patients at peak bed occupancy•a lower mortality rate from Omicron compared to previous waves T...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of infectious diseases Vol. 116; pp. 38 - 42
Main Authors Abdullah, F., Myers, J., Basu, D., Tintinger, G., Ueckermann, V., Mathebula, M., Ramlall, R., Spoor, S., de Villiers, T., Van der Walt, Z., Cloete, J., Soma-Pillay, P., Rheeder, P., Paruk, F., Engelbrecht, A., Lalloo, V., Myburg, M., Kistan, J., van Hougenhouck-Tulleken, W., Boswell, M.T., Gray, G., Welch, R., Blumberg, L., Jassat, W.
Format Journal Article
LanguageEnglish
Published Canada Elsevier Ltd 01.03.2022
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •the rapid rise and decline of admissions and decreased severity of COVID-19 disease•compares 466 patients in the Omicron wave to 3962 patients in previous waves•describes disease severity of all admitted patients at peak bed occupancy•a lower mortality rate from Omicron compared to previous waves The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves. 466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council. For the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years. Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave. Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deaths compared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital. There was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre.
AbstractList INTRODUCTION: The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves. METHODS: 466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council. RESULTS: For the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years.Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave.Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deathscompared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital. CONCLUSION: There was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre.
The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves. 466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council. For the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years. Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave. Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deaths compared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital. There was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre.
The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves.INTRODUCTIONThe coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves.466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council.METHODS466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council.For the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years. Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave. Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deaths compared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital.RESULTSFor the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years. Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave. Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deaths compared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital.There was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre.CONCLUSIONThere was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre.
•the rapid rise and decline of admissions and decreased severity of COVID-19 disease•compares 466 patients in the Omicron wave to 3962 patients in previous waves•describes disease severity of all admitted patients at peak bed occupancy•a lower mortality rate from Omicron compared to previous waves The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of people worldwide. To date there have been more than 274 million reported cases and 5.3 million deaths. The Omicron variant first documented in the City of Tshwane, Gauteng Province, South Africa on 9 November 2021 led to exponential increases in cases and a sharp rise in hospital admissions. The clinical profile of patients admitted at a large hospital in Tshwane is compared with previous waves. 466 hospital COVID-19 admissions since 14 November 2021 were compared to 3962 admissions since 4 May 2020, prior to the Omicron outbreak. Ninety-eight patient records at peak bed occupancy during the outbreak were reviewed for primary indication for admission, clinical severity, oxygen supplementation level, vaccination and prior COVID-19 infection. Provincial and city-wide daily cases and reported deaths, hospital admissions and excess deaths data were sourced from the National Institute for Communicable Diseases, the National Department of Health and the South African Medical Research Council. For the Omicron and previous waves, deaths and ICU admissions were 4.5% vs 21.3% (p<0.00001), and 1% vs 4.3% (p<0.00001) respectively; length of stay was 4.0 days vs 8.8 days; and mean age was 39 years vs 49,8 years. Admissions in the Omicron wave peaked and declined rapidly with peak bed occupancy at 51% of the highest previous peak during the Delta wave. Sixty two (63%) patients in COVID-19 wards had incidental COVID-19 following a positive SARS-CoV-2 PCR test . Only one third (36) had COVID-19 pneumonia, of which 72% had mild to moderate disease. The remaining 28% required high care or ICU admission. Fewer than half (45%) of patients in COVID-19 wards required oxygen supplementation compared to 99.5% in the first wave. The death rate in the face of an exponential increase in cases during the Omicron wave at the city and provincial levels shows a decoupling of cases and deaths compared to previous waves, corroborating the clinical findings of decreased severity of disease seen in patients admitted to the Steve Biko Academic Hospital. There was decreased severity of COVID-19 disease in the Omicron-driven fourth wave in the City of Tshwane, its first global epicentre.
Author Ueckermann, V.
Soma-Pillay, P.
Gray, G.
Welch, R.
Ramlall, R.
Abdullah, F.
Mathebula, M.
Spoor, S.
Paruk, F.
Boswell, M.T.
Jassat, W.
Cloete, J.
Myburg, M.
Van der Walt, Z.
Basu, D.
de Villiers, T.
Lalloo, V.
Myers, J.
van Hougenhouck-Tulleken, W.
Rheeder, P.
Kistan, J.
Blumberg, L.
Tintinger, G.
Engelbrecht, A.
Author_xml – sequence: 1
  givenname: F.
  orcidid: 0000-0002-1118-9430
  surname: Abdullah
  fullname: Abdullah, F.
  organization: Division of Infectious Diseases, Steve Biko Academic Hospital
– sequence: 2
  givenname: J.
  orcidid: 0000-0002-3939-4874
  surname: Myers
  fullname: Myers, J.
  organization: School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town
– sequence: 3
  givenname: D.
  orcidid: 0000-0002-4117-6817
  surname: Basu
  fullname: Basu, D.
  organization: Department of Public Health Medicine, University of Pretoria
– sequence: 4
  givenname: G.
  surname: Tintinger
  fullname: Tintinger, G.
  organization: Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria
– sequence: 5
  givenname: V.
  orcidid: 0000-0002-4419-3583
  surname: Ueckermann
  fullname: Ueckermann, V.
  organization: Division of Infectious Diseases, Steve Biko Academic Hospital
– sequence: 6
  givenname: M.
  surname: Mathebula
  fullname: Mathebula, M.
  organization: Steve Biko Academic Hospital
– sequence: 7
  givenname: R.
  surname: Ramlall
  fullname: Ramlall, R.
  organization: Tshwane District Hospital
– sequence: 8
  givenname: S.
  surname: Spoor
  fullname: Spoor, S.
  organization: Tshwane District Hospital
– sequence: 9
  givenname: T.
  surname: de Villiers
  fullname: de Villiers, T.
  organization: Tshwane District Hospital
– sequence: 10
  givenname: Z.
  surname: Van der Walt
  fullname: Van der Walt, Z.
  organization: Tshwane District Hospital
– sequence: 11
  givenname: J.
  orcidid: 0000-0001-6548-2475
  surname: Cloete
  fullname: Cloete, J.
  organization: Department of Paediatrics, Steve Biko Academic Hospital and University of Pretoria
– sequence: 12
  givenname: P.
  surname: Soma-Pillay
  fullname: Soma-Pillay, P.
  organization: Department of Obstetrics, Steve Biko Academic Hospital and University of Pretoria
– sequence: 13
  givenname: P.
  surname: Rheeder
  fullname: Rheeder, P.
  organization: Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria
– sequence: 14
  givenname: F.
  orcidid: 0000-0002-6549-0106
  surname: Paruk
  fullname: Paruk, F.
  organization: Department of Critical Care, Steve Biko Academic Hospital and University of Pretoria
– sequence: 15
  givenname: A.
  surname: Engelbrecht
  fullname: Engelbrecht, A.
  organization: Department of Emergency Medicine, Steve Biko Academic Hospital and University of Pretoria
– sequence: 16
  givenname: V.
  orcidid: 0000-0002-5547-8461
  surname: Lalloo
  fullname: Lalloo, V.
  organization: Department of Emergency Medicine, Steve Biko Academic Hospital and University of Pretoria
– sequence: 17
  givenname: M.
  surname: Myburg
  fullname: Myburg, M.
  organization: Steve Biko Academic Hospital
– sequence: 18
  givenname: J.
  orcidid: 0000-0002-9446-0918
  surname: Kistan
  fullname: Kistan, J.
  organization: Department of Public Health Medicine, University of Pretoria
– sequence: 19
  givenname: W.
  surname: van Hougenhouck-Tulleken
  fullname: van Hougenhouck-Tulleken, W.
  organization: Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria
– sequence: 20
  givenname: M.T.
  surname: Boswell
  fullname: Boswell, M.T.
  organization: Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria
– sequence: 21
  givenname: G.
  surname: Gray
  fullname: Gray, G.
  organization: South African Medical Research Council
– sequence: 22
  givenname: R.
  surname: Welch
  fullname: Welch, R.
  organization: National Institute of Communicable Diseases
– sequence: 23
  givenname: L.
  surname: Blumberg
  fullname: Blumberg, L.
  organization: National Institute of Communicable Diseases
– sequence: 24
  givenname: W.
  surname: Jassat
  fullname: Jassat, W.
  organization: National Institute of Communicable Diseases
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34971823$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1v1DAUjFAR_YA_wAH5yIEsfk6cOAghofJVqRIXOFuO87z7ttm42N5Fe-eH47Cloj2Uk63xzDzrzZwWR5OfsCieA18Ah-b1ekFrGhaCC1iAWFSyfVScgGpVWUmAo3wXHMquBXFcnMa45pzXTaOeFMdVnVElqpPi1we0AU3EgUXcYaC0Z96xgeIMsmEbaFqytELmKMTElqPvzcj8hmzwE9uZQGZKzPodDSV0zG9Tn_2uGE3MsNGEJbKVj9eUsipjKa5-mglfsZiZK2ZcIGueFo-dGSM-uznPiu-fPn47_1Jefv18cf7-srRNpVIpmx4GKXveVJ1oueLCQOfACOsU1iihQwFGysE5rJSTGVFDLYFbYbAXsjorLg6-gzdrfR1oY8Jee0P6D-DDUpuQyI6oFUKPvZV5eVgr1Rrr8pDWyQZtVWGfvd4dvK63_QYHi1MKZrxjevdlopVe-p1WLVQ1NNng5Y1B8D-2GJPeULQ4jnk9fhu1aEB20Eo5U1_8O-t2yN8YM0EcCDmUGAO6WwpwPXdFr_XcFT13RYPQuStZpO6JbE4pkZ__S-PD0rcHKea0doRBR0s4WRwooE15nfSw_M09uR1pykUYr3D_P_FvgaHwRw
CitedBy_id crossref_primary_10_1111_eci_14004
crossref_primary_10_1016_j_semerg_2023_102073
crossref_primary_10_1109_TASE_2022_3224171
crossref_primary_10_1136_bmjopen_2022_061752
crossref_primary_10_47203_IJCH_2022_v34i02_006
crossref_primary_10_1016_j_clrc_2024_100194
crossref_primary_10_1016_j_msard_2022_103803
crossref_primary_10_2139_ssrn_4053482
crossref_primary_10_1016_j_gloepi_2024_100181
crossref_primary_10_7759_cureus_41200
crossref_primary_10_1080_22221751_2023_2276338
crossref_primary_10_1001_jamanetworkopen_2022_26436
crossref_primary_10_1016_j_gene_2024_148970
crossref_primary_10_1016_j_medcle_2022_05_017
crossref_primary_10_7759_cureus_25196
crossref_primary_10_3390_jcm12185904
crossref_primary_10_1620_tjem_2022_J067
crossref_primary_10_1016_j_resinv_2022_08_001
crossref_primary_10_1186_s12985_024_02538_0
crossref_primary_10_3390_jcm11144038
crossref_primary_10_1080_13814788_2022_2154074
crossref_primary_10_2217_fvl_2022_0003
crossref_primary_10_3389_fmicb_2022_854567
crossref_primary_10_1186_s12880_022_00833_2
crossref_primary_10_1016_j_medcli_2022_05_010
crossref_primary_10_1093_infdis_jiad057
crossref_primary_10_1001_jamanetworkopen_2023_9050
crossref_primary_10_1007_s11684_023_1043_5
crossref_primary_10_1016_j_pediatrneurol_2024_01_008
crossref_primary_10_1177_14034948221108548
crossref_primary_10_1128_jvi_00961_22
crossref_primary_10_1055_s_0042_1751312
crossref_primary_10_1111_imm_13487
crossref_primary_10_3389_fmed_2023_1079165
crossref_primary_10_3389_fimmu_2022_914167
crossref_primary_10_1016_S1473_3099_22_00154_2
crossref_primary_10_3389_fpubh_2023_1143650
crossref_primary_10_1111_jocn_16721
crossref_primary_10_5588_ijtldopen_23_0053
crossref_primary_10_22207_JPAM_16_3_45
crossref_primary_10_4102_jtscm_v17i0_881
crossref_primary_10_1177_23814683231222469
crossref_primary_10_3390_ijms231911291
crossref_primary_10_3389_fmed_2023_1256080
crossref_primary_10_3390_ijms23041987
crossref_primary_10_3390_ijerph20042779
crossref_primary_10_1016_j_jiac_2022_09_005
crossref_primary_10_1186_s12916_023_03235_5
crossref_primary_10_5582_bst_2022_01062
crossref_primary_10_3389_fimmu_2022_1010140
crossref_primary_10_17816_clinpract322036
crossref_primary_10_1002_rmv_2398
crossref_primary_10_2139_ssrn_4065233
crossref_primary_10_1016_j_idnow_2023_104713
crossref_primary_10_1080_21645515_2024_2436714
crossref_primary_10_1186_s12887_025_05524_9
crossref_primary_10_4236_aid_2022_123042
crossref_primary_10_1016_j_mran_2022_100217
crossref_primary_10_1016_j_jiph_2023_01_013
crossref_primary_10_1186_s12985_024_02531_7
crossref_primary_10_1002_iid3_606
crossref_primary_10_1136_bmjopen_2023_076959
crossref_primary_10_1017_ice_2024_3
crossref_primary_10_25259_JRHM_11_2022
crossref_primary_10_2169_internalmedicine_1399_22
crossref_primary_10_2478_slgr_2023_0004
crossref_primary_10_1186_s41479_022_00099_w
crossref_primary_10_3390_vaccines10060940
crossref_primary_10_1007_s00268_023_07222_y
crossref_primary_10_1111_anae_15699
crossref_primary_10_1186_s40001_024_01840_5
crossref_primary_10_1016_j_virs_2022_07_014
crossref_primary_10_1016_j_scitotenv_2022_158028
crossref_primary_10_1186_s12879_025_10585_3
crossref_primary_10_1089_aid_2022_0048
crossref_primary_10_1001_jamanetworkopen_2022_46152
crossref_primary_10_12677_AMB_2022_112006
crossref_primary_10_3390_v14112377
crossref_primary_10_3390_v14112499
crossref_primary_10_1016_j_ceh_2023_10_002
crossref_primary_10_1093_ofid_ofac262
crossref_primary_10_3390_v14122736
crossref_primary_10_5662_wjm_v14_i3_89761
crossref_primary_10_7883_yoken_JJID_2024_071
crossref_primary_10_1177_17534666231209150
crossref_primary_10_1097_MD_0000000000029165
crossref_primary_10_3390_vaccines10111901
crossref_primary_10_4081_monaldi_2022_2324
crossref_primary_10_3390_diagnostics13030559
crossref_primary_10_58318_2957_5702_2022_9_44_54
crossref_primary_10_29235_1814_6023_2023_20_1_34_41
crossref_primary_10_3390_organoids1010002
crossref_primary_10_1016_j_jinf_2022_10_004
crossref_primary_10_1186_s12916_023_03234_6
crossref_primary_10_1016_j_ijid_2022_03_023
crossref_primary_10_1186_s12879_022_07777_6
crossref_primary_10_1016_j_lansea_2022_100023
crossref_primary_10_57187_s_3636
crossref_primary_10_1186_s12885_024_13020_z
crossref_primary_10_1007_s10753_022_01734_w
crossref_primary_10_2147_RMHP_S375021
crossref_primary_10_1080_22221751_2022_2093135
crossref_primary_10_1093_oncolo_oyad121
crossref_primary_10_1016_j_ijregi_2022_11_008
crossref_primary_10_4103_ed_ed_5_22
crossref_primary_10_1177_2632010X221124908
crossref_primary_10_1001_jamanetworkopen_2022_55599
crossref_primary_10_4081_monaldi_2022_2337
crossref_primary_10_1245_s10434_024_16297_3
crossref_primary_10_1038_s41467_022_35480_2
crossref_primary_10_1038_s41577_022_00720_5
crossref_primary_10_1080_07853890_2023_2274510
crossref_primary_10_3390_healthcare11121703
crossref_primary_10_23736_S2784_8477_23_02103_4
crossref_primary_10_7759_cureus_48046
crossref_primary_10_1111_apa_16576
crossref_primary_10_22159_ijcpr_2024v16i6_6014
crossref_primary_10_3389_fimmu_2022_856072
crossref_primary_10_1007_s40259_022_00529_7
crossref_primary_10_1016_j_eclinm_2022_101455
crossref_primary_10_1097_MAT_0000000000002334
crossref_primary_10_3390_biom12101353
crossref_primary_10_1007_s40520_023_02415_w
crossref_primary_10_1080_03007995_2023_2223917
crossref_primary_10_1093_infdis_jiac411
crossref_primary_10_3390_biom12050631
crossref_primary_10_4049_jimmunol_2200175
crossref_primary_10_4103_JME_JME_80_22
crossref_primary_10_4103_jacp_jacp_4_22
crossref_primary_10_1371_journal_pone_0281326
crossref_primary_10_1002_ccr3_5934
crossref_primary_10_1016_j_eimc_2022_11_003
crossref_primary_10_3389_fmicb_2022_923546
crossref_primary_10_3389_fimmu_2023_1257360
crossref_primary_10_1016_j_ijid_2023_01_030
crossref_primary_10_3390_ijms23169058
crossref_primary_10_1371_journal_pone_0291580
crossref_primary_10_1016_j_cell_2023_08_026
crossref_primary_10_1038_s41598_024_60841_w
crossref_primary_10_3346_jkms_2022_37_e246
crossref_primary_10_3390_zoonoticdis4040023
crossref_primary_10_1038_s41598_022_21690_7
crossref_primary_10_1016_j_jiac_2022_08_004
crossref_primary_10_1053_j_jvca_2025_02_015
crossref_primary_10_2217_fon_2022_0024
crossref_primary_10_36604_1998_5029_2023_88_59_68
crossref_primary_10_15585_mmwr_mm7106e2
crossref_primary_10_3390_antibiotics12020393
crossref_primary_10_1002_jmv_28214
crossref_primary_10_1111_irv_13019
crossref_primary_10_1371_journal_pone_0276774
crossref_primary_10_1016_j_envres_2022_114446
crossref_primary_10_4103_jalh_jalh_38_23
crossref_primary_10_1186_s44158_022_00058_3
crossref_primary_10_1111_anae_16061
crossref_primary_10_1186_s12864_024_10973_0
crossref_primary_10_3389_fmicb_2022_1061879
crossref_primary_10_1016_j_ijid_2023_02_020
crossref_primary_10_1186_s12879_022_07941_y
crossref_primary_10_1126_scitranslmed_abm2311
crossref_primary_10_1186_s40246_022_00392_1
crossref_primary_10_1016_j_cell_2022_03_038
crossref_primary_10_1016_j_arbres_2022_06_001
crossref_primary_10_1080_22221751_2022_2103455
crossref_primary_10_1016_j_virs_2022_02_001
crossref_primary_10_3390_v14061297
crossref_primary_10_3390_biomedicines11082113
crossref_primary_10_3892_etm_2024_12372
crossref_primary_10_1016_j_ijid_2022_07_005
crossref_primary_10_3389_fimmu_2022_1094727
crossref_primary_10_1016_j_genrep_2022_101549
crossref_primary_10_2144_fsoa_2023_0024
crossref_primary_10_1016_j_jfma_2024_11_016
crossref_primary_10_3390_biomedicines11041143
crossref_primary_10_1002_mco2_172
crossref_primary_10_1016_S2352_4642_22_00060_8
crossref_primary_10_22207_JPAM_17_3_46
crossref_primary_10_3390_vaccines12121303
crossref_primary_10_1016_j_hbpd_2024_01_001
crossref_primary_10_1038_s41392_022_00997_x
crossref_primary_10_1016_j_ijmmb_2022_12_004
crossref_primary_10_1136_bmjgh_2023_012328
crossref_primary_10_1016_j_biopha_2022_112767
crossref_primary_10_3389_fpubh_2022_903568
crossref_primary_10_1002_jmv_28477
crossref_primary_10_1016_j_ijid_2022_04_029
crossref_primary_10_3390_vaccines10081362
crossref_primary_10_2147_IJGM_S391024
crossref_primary_10_3389_fimmu_2024_1359380
crossref_primary_10_3390_v14061181
crossref_primary_10_1016_j_xcrm_2023_101361
crossref_primary_10_1155_2023_8846953
crossref_primary_10_2139_ssrn_4289504
crossref_primary_10_3389_fmicb_2024_1334152
crossref_primary_10_1111_petr_14235
crossref_primary_10_1007_s12033_023_00919_4
crossref_primary_10_1097_YIC_0000000000000491
crossref_primary_10_1093_cid_ciac705
crossref_primary_10_3346_jkms_2024_39_e150
crossref_primary_10_3389_fpubh_2022_1014470
crossref_primary_10_3390_vaccines11010126
crossref_primary_10_1002_ijgo_14934
crossref_primary_10_1186_s12913_025_12482_6
crossref_primary_10_3390_md20020148
crossref_primary_10_3389_fpubh_2024_1294261
crossref_primary_10_1016_j_eimce_2022_11_021
crossref_primary_10_1016_j_jiph_2022_12_003
crossref_primary_10_15585_mmwr_mm7104e4
crossref_primary_10_3390_vaccines12060645
crossref_primary_10_1016_j_cmi_2023_03_017
crossref_primary_10_1155_2023_4940767
crossref_primary_10_1016_j_jinf_2024_106121
crossref_primary_10_15407_fz69_01_035
crossref_primary_10_3390_diagnostics12082010
crossref_primary_10_3390_jcm13123477
crossref_primary_10_1016_S2352_4642_22_00059_1
crossref_primary_10_1016_j_anzjph_2024_100170
crossref_primary_10_1371_journal_pone_0268734
crossref_primary_10_32997_rcb_2022_3778
crossref_primary_10_1128_jvi_01351_23
crossref_primary_10_1080_02640414_2024_2312054
crossref_primary_10_1080_14656566_2023_2262387
crossref_primary_10_1001_jamaoncol_2023_2271
crossref_primary_10_13105_wjma_v10_i3_177
crossref_primary_10_3390_children9071043
crossref_primary_10_1038_s41467_024_46692_z
crossref_primary_10_1002_ijgo_14348
crossref_primary_10_3389_fepid_2022_891162
crossref_primary_10_3390_ijms25147537
crossref_primary_10_1016_j_radcr_2022_06_034
crossref_primary_10_4178_epih_e2022034
crossref_primary_10_2147_IDR_S380005
crossref_primary_10_1177_03000605221086433
crossref_primary_10_37737_ace_23005
crossref_primary_10_1292_jvms_23_0205
crossref_primary_10_1016_j_lfs_2022_120392
crossref_primary_10_3892_etm_2022_11343
crossref_primary_10_1038_s41467_022_31200_y
crossref_primary_10_1093_cid_ciac802
crossref_primary_10_1002_acn3_51833
crossref_primary_10_1016_j_ijregi_2022_07_005
crossref_primary_10_24018_ejmed_2022_4_3_1258
crossref_primary_10_3390_ijms241411614
crossref_primary_10_3390_v15010149
crossref_primary_10_1055_a_1956_9641
crossref_primary_10_1002_jmv_27613
crossref_primary_10_1016_j_ebiom_2023_104924
crossref_primary_10_1021_acsmaterialslett_3c01442
crossref_primary_10_1186_s12871_024_02600_y
crossref_primary_10_3390_v15030618
crossref_primary_10_2147_IJGM_S429870
crossref_primary_10_1002_jmv_28034
crossref_primary_10_1002_jmv_28831
crossref_primary_10_1002_jso_27425
crossref_primary_10_1186_s13059_023_02881_5
crossref_primary_10_1056_NEJMoa2203209
crossref_primary_10_1080_14787210_2022_2077191
crossref_primary_10_3389_fimmu_2023_1189482
crossref_primary_10_7326_M22_0308
crossref_primary_10_3389_fpubh_2022_876551
crossref_primary_10_30934_kusbed_1060956
crossref_primary_10_1016_j_bbadis_2022_166582
crossref_primary_10_1016_j_hbpd_2024_09_009
crossref_primary_10_2147_JIR_S420721
crossref_primary_10_2147_IDR_S450504
crossref_primary_10_1016_j_legalmed_2023_102222
crossref_primary_10_1515_cclm_2022_1287
crossref_primary_10_3390_v16040649
crossref_primary_10_1016_S0140_6736_22_00462_7
crossref_primary_10_3390_jcm11247452
crossref_primary_10_3390_tropicalmed9110266
crossref_primary_10_1016_j_jhin_2023_01_018
crossref_primary_10_1080_22221751_2022_2095932
crossref_primary_10_1016_S2214_109X_22_00359_X
crossref_primary_10_1016_j_bjid_2024_103721
crossref_primary_10_3390_microorganisms10040806
crossref_primary_10_1093_ofid_ofac502
crossref_primary_10_3892_etm_2023_12097
crossref_primary_10_1016_j_mayocpiqo_2023_07_004
crossref_primary_10_1371_journal_pone_0282806
crossref_primary_10_1186_s42269_022_00879_w
crossref_primary_10_3390_ijerph191912019
crossref_primary_10_1002_jmv_29143
crossref_primary_10_1038_s41586_021_04387_1
crossref_primary_10_3390_children9101542
Cites_doi 10.1101/2021.12.20.21268096
10.21203/rs.3.rs-1156502/v1
ContentType Journal Article
Copyright 2021 The Author(s)
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
2021 The Author(s) 2021
Copyright_xml – notice: 2021 The Author(s)
– notice: Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
– notice: 2021 The Author(s) 2021
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1016/j.ijid.2021.12.357
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1878-3511
EndPage 42
ExternalDocumentID oai_doaj_org_article_8e1bebc5712e4887acff8e7f56ec33eb
PMC8713416
34971823
10_1016_j_ijid_2021_12_357
S120197122101256X
Genre Journal Article
GeographicLocations South Africa
GeographicLocations_xml – name: South Africa
GroupedDBID ---
--K
.1-
.FO
.~1
0R~
1B1
1P~
1~.
1~5
29J
3O-
4.4
457
4G.
53G
5GY
5VS
7-5
71M
7X7
88E
8C1
8FI
8FJ
8FQ
8R4
8R5
AAEDW
AAFWJ
AAIKJ
AALRI
AAQFI
AAQXK
AARKO
AAXUO
AAYWO
ABBQC
ABFRF
ABMAC
ABUWG
ABWVN
ACGFO
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEFWE
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFJKZ
AFKRA
AFPKN
AFPUW
AFRHN
AFTJW
AGEKW
AGHFR
AGQPQ
AGYEJ
AHMBA
AIGII
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BAWUL
BCNDV
BENPR
BPHCQ
BR6
BVXVI
CCPQU
CS3
DIK
DU5
DWQXO
E3Z
EBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FNPLU
FYUFA
G-Q
GBLVA
GROUPED_DOAJ
GX1
HMCUK
HVGLF
HZ~
IHE
IXB
J1W
KQ8
M1P
M3C
M3G
M41
MO0
N9A
O-L
O9-
OD-
OK1
OO.
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
Q2X
Q38
QTD
R2-
ROL
RPZ
RWL
RXW
SDF
SDG
SEL
SES
SEW
SSZ
TAE
UKHRP
UNMZH
Z5R
0SF
3V.
6I.
AACTN
AAFTH
ABVKL
AFCTW
NCXOZ
RIG
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c638t-56b1d55b0639270802a19f1a2cf8e4e519e21a55dffe38f5e518d4510c2aeb253
IEDL.DBID DOA
ISSN 1201-9712
1878-3511
IngestDate Wed Aug 27 01:32:00 EDT 2025
Thu Aug 21 18:45:39 EDT 2025
Fri Jul 11 00:17:10 EDT 2025
Thu Apr 24 04:15:05 EDT 2025
Thu Apr 24 23:07:04 EDT 2025
Tue Jul 01 04:30:10 EDT 2025
Fri Feb 23 02:40:11 EST 2024
Tue Aug 26 16:32:04 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords SAMRC
SBAH
COVID-19
Tshwane
NICD
South Africa
NDOH
UP
Omicron
disease severity
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c638t-56b1d55b0639270802a19f1a2cf8e4e519e21a55dffe38f5e518d4510c2aeb253
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-4117-6817
0000-0002-3939-4874
0000-0002-4419-3583
0000-0002-6549-0106
0000-0002-9446-0918
0000-0002-5547-8461
0000-0001-6548-2475
0000-0002-1118-9430
OpenAccessLink https://doaj.org/article/8e1bebc5712e4887acff8e7f56ec33eb
PMID 34971823
PQID 2615917556
PQPubID 23479
PageCount 5
ParticipantIDs doaj_primary_oai_doaj_org_article_8e1bebc5712e4887acff8e7f56ec33eb
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8713416
proquest_miscellaneous_2615917556
pubmed_primary_34971823
crossref_primary_10_1016_j_ijid_2021_12_357
crossref_citationtrail_10_1016_j_ijid_2021_12_357
elsevier_sciencedirect_doi_10_1016_j_ijid_2021_12_357
elsevier_clinicalkey_doi_10_1016_j_ijid_2021_12_357
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-03-01
PublicationDateYYYYMMDD 2022-03-01
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-01
  day: 01
PublicationDecade 2020
PublicationPlace Canada
PublicationPlace_xml – name: Canada
PublicationTitle International journal of infectious diseases
PublicationTitleAlternate Int J Infect Dis
PublicationYear 2022
Publisher Elsevier Ltd
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases
– name: Elsevier
References (accessed 20 December 2021) 2021
(accessed Dec 10, 2021) 2021
Bradshaw D. et al. Estimated natural deaths of persons 1+years. South Africa Medical Research Council.
Stata/IC 16. 1 for Mac Revision 31 Mar 2020
Boswell T. et al. COVID-19 severity and in-hospital mortality in an area with high HIV prevalence, 09 December 2021, PREPRINT (Version 1) available at Research Square [ https://doi.org/10.21203/rs.3.rs-1156502/v1 ]
accessed 23 December 2021
World Health Organisation.
Mendelsohn (bib0004) 2021
(accessed 22 December 2021) 2021.
Maslo (bib13) 2021
COVID-19 Wkly. Epidemiol. BRIEF, WEEK 48 2021. https://www.nicd.ac.za/wp-content/uploads/2021/12/COVID-19-Weekly-Epidemiology-Brief-week-48-2021.pdf (accessed 20 December 2021) 2021.
National Department of Health. COVID-19 statistics in South Africa.
(accessed 11 December 2021) 2021
Viana R. et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. medRxiv, MEDRXIV-2021-268028v1-deOliveira: (2021).
World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern.
National Institute for Communicable Diseases.
Network for Genomics Surveillance in South Africa (NGS-SA). SARS-CoV-2 Genomic Surveillance Update.
(accessed 20 December 2021) 2021.
Madhi Shabir A., et al. South African Population Immunity and Severe Covid-19 with Omicron Variant. Shabir A. Madhi, et al 2021
Office of the Executive Mayor
10.1016/j.ijid.2021.12.357_bib0009
10.1016/j.ijid.2021.12.357_bib0005
10.1016/j.ijid.2021.12.357_bib0006
10.1016/j.ijid.2021.12.357_bib0007
10.1016/j.ijid.2021.12.357_bib0008
10.1016/j.ijid.2021.12.357_bib0001
Maslo (10.1016/j.ijid.2021.12.357_bib13) 2021
10.1016/j.ijid.2021.12.357_bib0012
10.1016/j.ijid.2021.12.357_bib0002
Mendelsohn (10.1016/j.ijid.2021.12.357_bib0004) 2021
10.1016/j.ijid.2021.12.357_bib0003
10.1016/j.ijid.2021.12.357_bib0010
10.1016/j.ijid.2021.12.357_bib0011
References_xml – reference: (accessed 20 December 2021) 2021
– reference: (accessed 11 December 2021) 2021
– reference: Stata/IC 16. 1 for Mac Revision 31 Mar 2020
– reference: (accessed 23 December 2021)
– reference: Network for Genomics Surveillance in South Africa (NGS-SA). SARS-CoV-2 Genomic Surveillance Update.
– reference: (accessed 20 December 2021) 2021.
– year: 2021
  ident: bib13
  publication-title: JAMA
– reference: National Institute for Communicable Diseases.
– reference: (accessed Dec 10, 2021) 2021
– reference: (accessed 22 December 2021) 2021.
– reference: Boswell T. et al. COVID-19 severity and in-hospital mortality in an area with high HIV prevalence, 09 December 2021, PREPRINT (Version 1) available at Research Square [ https://doi.org/10.21203/rs.3.rs-1156502/v1 ]
– reference: National Department of Health. COVID-19 statistics in South Africa.
– reference: . COVID-19 Wkly. Epidemiol. BRIEF, WEEK 48 2021. https://www.nicd.ac.za/wp-content/uploads/2021/12/COVID-19-Weekly-Epidemiology-Brief-week-48-2021.pdf (accessed 20 December 2021) 2021.
– reference: Office of the Executive Mayor
– reference: Viana R. et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. medRxiv, MEDRXIV-2021-268028v1-deOliveira: (2021).
– reference: World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern.
– year: 2021
  ident: bib0004
  article-title: COVID-19 wave 4 in Western Cape Province, South Africa: Fewer hospitalisations, but new challenges for a depleted workforce
  publication-title: S Afr Med J.
– reference: Madhi Shabir A., et al. South African Population Immunity and Severe Covid-19 with Omicron Variant. Shabir A. Madhi, et al 2021,
– reference: Bradshaw D. et al. Estimated natural deaths of persons 1+years. South Africa Medical Research Council.
– reference: World Health Organisation.
– ident: 10.1016/j.ijid.2021.12.357_bib0003
  doi: 10.1101/2021.12.20.21268096
– ident: 10.1016/j.ijid.2021.12.357_bib0011
– ident: 10.1016/j.ijid.2021.12.357_bib0010
– ident: 10.1016/j.ijid.2021.12.357_bib0012
– year: 2021
  ident: 10.1016/j.ijid.2021.12.357_bib13
  publication-title: JAMA
– ident: 10.1016/j.ijid.2021.12.357_bib0005
– ident: 10.1016/j.ijid.2021.12.357_bib0001
  doi: 10.21203/rs.3.rs-1156502/v1
– year: 2021
  ident: 10.1016/j.ijid.2021.12.357_bib0004
  article-title: COVID-19 wave 4 in Western Cape Province, South Africa: Fewer hospitalisations, but new challenges for a depleted workforce
  publication-title: S Afr Med J.
– ident: 10.1016/j.ijid.2021.12.357_bib0006
– ident: 10.1016/j.ijid.2021.12.357_bib0007
– ident: 10.1016/j.ijid.2021.12.357_bib0008
– ident: 10.1016/j.ijid.2021.12.357_bib0009
– ident: 10.1016/j.ijid.2021.12.357_bib0002
SSID ssj0004668
Score 2.68172
Snippet •the rapid rise and decline of admissions and decreased severity of COVID-19 disease•compares 466 patients in the Omicron wave to 3962 patients in previous...
The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and wellbeing of...
INTRODUCTION: The coronavirus disease 2019 (COVID-19) first reported in Wuhan, China in December 2019 is a global pandemic that is threatening the health and...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 38
SubjectTerms Adult
COVID-19
COVID-19 - epidemiology
Disease Outbreaks
disease severity
Hospitals
Humans
Omicron
SARS-CoV-2
Severity of Illness Index
South Africa
South Africa - epidemiology
Tshwane
SummonAdditionalLinks – databaseName: Elsevier SD Freedom Collection
  dbid: .~1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqHhASQqW8wktG4gZh61ecHKFQVUjlApX2ZjmOzaZUSbWPcuPED2cmdlYbkIrELXLsTbzzeTwTzzdDyKsjZ1Whnc-DalwOK5HnVQ1XutLgYZeFqxrkO599Lk7P5ae5mu-R45ELg2GVSfdHnT5o69QyS__m7KptZ18Y7F2VZpxjiipVzJHBLjWi_O1PtsONjHQ46Jxj70SciTFe7UWL2UI5w0-CAreonc1pyOE_2aP-tkH_DKXc2ZtODsjdZFTSd_G975E93x2SW2fp2PyQ3Ikf52jkHN0nvz4MxuLKNxQe6rF-He0DTYc1NFIXKZiGNLRgHdKYNYQigXnZd_Qa_GsQCHVI4stZRfvNGjxr-522HbX0EoPL6SIVJMG29Wrxw3b-DV1hwT5qh9pED8j5ycevx6d5KseQO1ik61wVNWuUqtGo4Ro5upZVgVnuQumlB1PQc2aVakLwogwKWspGwpp33IL_rsRDst_1nX9MaMUcIEdKZWshpdO1D0fOF5w3jaqZkBlhoxyMS7nKsWTGpRmD0i4Mys6g7AzjBmSXkdfbMVcxU8eNvd-jeLc9Mcv20NAvv5kEM1N6VvvaKYCNB0WnrQswVR1U4Z0Qvs6IGMFhRiIrqF74ofbGR6vtqAnU_znu5Yg_AzoAD3ZAdP1mZcALVuB2K1Vk5FHE43ZiQgLqSy4yoidIncx8eqdrF0Oe8RJ5xqx48p_v-5Tc5sgVGQL2npH99XLjn4MFt65fDEv0NzLcRjw
  priority: 102
  providerName: Elsevier
Title Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa
URI https://www.clinicalkey.com/#!/content/1-s2.0-S120197122101256X
https://dx.doi.org/10.1016/j.ijid.2021.12.357
https://www.ncbi.nlm.nih.gov/pubmed/34971823
https://www.proquest.com/docview/2615917556
https://pubmed.ncbi.nlm.nih.gov/PMC8713416
https://doaj.org/article/8e1bebc5712e4887acff8e7f56ec33eb
Volume 116
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagB4SEEJRXeFSDxA0CtR3ncaSUqgWVE5X2ZtmOrU2pEtTNwo0TP5yZOIl2QWovXKKVE2_kzEzmm3i-GcZe7Tuj8sL5NKjapWiJIq0s_iqqAiPsMndVTXzn0y_58Vn2aaEWG62-KCcslgeOD-5d6bn11qmCC4_KVhgXQumLoHLvpPSW3r7o86ZgamZERhIcure0wqkjXSZmdjXnDdUIFZw-BEpyTBsuaajcv-WZ_kWefydQbniko3vs7ggl4X1cwn12w7e77NbpuFm-y-7ET3IQmUYP2O_DASKufA14U09d66ALMG7RQCQsAgJCCA1iQoi1QoBoy5ddCz8wqkYxgCPqXsor6NY9xtPmGzQtGLiglHJYjm1IaKxfLX-a1r-BFbXpAzN0JHrIzo4-fv1wnI5NGFKHptmnKre8VsoSlBEFMXMNrwI3wqEYMo8A0AtulKpD8LIMCkfKOkNLd8Jg1K7kI7bTdq1_wqDiDvUly5SxMstcYX3Ydz4Xoq6V5TJLGJ_koN1YoZwaZVzoKRXtXJPsNMlOc6FRdgl7Pc_5HutzXHn1AYl3vpJqaw8DqHF61Dh9ncYlTE7KoSf6Kr5w8Y-aK2-t5lkjuImg5dp5Lyf902j5tJ2DouvWK42xr8JgW6k8YY-jPs4LkxlqfSlkwootTd1a-faZtlkO1cVLYhfz_On_eFTP2G1BdJEhZ-852-kv1_4Fgrje7rGbb39xPB6efN4bbBePJ4uDP1RrSoU
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgESQlBeW16DBCdIt3biPA4cgFJtabcXWmlvxnFsNm2VVPug4sKJf8QfZCZxVrsgFQmpt5U3TuzM5_FMPN8MYy-3jZZxYmzgZGECXIkiyHL8lWQJethpbLKC-M7Dw3hwHH0aydEa-9VxYSis0uv-Vqc32tq39P3b7J-XZf8zx70rS7gQlKJKxiMfWblvv1-g3zZ9u7eDQn4lxO7How-DwJcWCAwCbhbIOOeFlDlt0CIhvqnmmeNaGJfayKJZYwXXUhbO2TB1ElvSIkL8GqHRF6VSEaj3r0WoLqhswtYPvkTGbPl3OLqAhueZOm1QWXlSUnpSwekbZEh74tJu2BQNWNkU_zZ6_4zdXNoMd--w296KhXfti7rL1my1wa4P_Tn9BrvVfg2EluR0j_3caazTqS0AH2qpYB7UDvzpELRcSUBbFFyJ5ii0aUqAGNOTuoJv6NAjAsAQazDgGdTzGbry-hTKCjScUTQ7jH0FFGqbTccXurJvYEoVAkE3xZDus-MrEdIDtl7VlX3EIOMGoRpFUudhFJkkt27b2FiIopA5D6Me450clPHJ0alGx5nqouBOFMlOkewUFwpl12OvF33O29Qgl179nsS7uJLSejcN9eSr8rhWqeW5zY1E2FjUrIk2DqeaOBlbE4Y277GwA4fqmLOo6_FG5aWPloteK2vrn_1edPhTqHToJAlFV8-nCt1uiX6-lHGPPWzxuJhYGCHqUxH2WLKC1JWZr_5TleMmsXlKxGYeb_7neJ-zG4Oj4YE62Dvcf8xuCiKqNNGCT9j6bDK3T9F8nOXPmuUK7MtV64ffHICCwg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decreased+severity+of+disease+during+the+first+global+omicron+variant+covid-19+outbreak+in+a+large+hospital+in+tshwane%2C+south+africa&rft.jtitle=International+journal+of+infectious+diseases&rft.au=Abdullah%2C+F.&rft.au=Myers%2C+J.&rft.au=Basu%2C+D.&rft.au=Tintinger%2C+G.&rft.date=2022-03-01&rft.issn=1201-9712&rft.volume=116&rft.spage=38&rft.epage=42&rft_id=info:doi/10.1016%2Fj.ijid.2021.12.357&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ijid_2021_12_357
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1201-9712&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1201-9712&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1201-9712&client=summon